A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).
NCT ID: NCT06067828
This clinical trial is studying the effects of a new inhaler that combines three medications—Budesonide, Glycopyrronium, and Formoterol Fumarate—on exercise performance in people with Chronic Obstr...
Recruiting
Phase: PHASE3
Type: interventional
Locations: Los Angeles, California, United States, Greenville, South Carolina, United States +32 more